InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,471.05
(
1.16%
)
US TECH 100
18,216.00
(
1.50%
)
Dow Jones
40,829.59
(
1.20%
)
Brent Oil
71.81
(
0.38%
)
Bitcoin
57,630.07
(
5.03%
)
Post# of 253072
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Biowatch

Send PM Follow Ignore
Followers 61
Posts 6682
Boards Moderated 1
Alias Born 10/18/2003

Biowatch

Member Level

Re: DewDiligence post# 115106

Tuesday, 12/20/2011 8:09:19 AM

Tuesday, December 20, 2011 8:09:19 AM

Post# of 253072
Three European companies douse hopes for new drugs
[How's that for a cheery headline?]

By Ben Hirschler and Elena Berton
LONDON/PARIS (Reuters) - Three of Europe's biggest drugmakers -- AstraZeneca (LSE:AZN.L - News), Novartis (VTX:NOVN.VX - News) and Sanofi (:SASY.PA) -- reported product setbacks on Tuesday, underlining the difficulties of developing new medicines to make up for those going off patent.


http://finance.yahoo.com/news/Three-European-companies-rb-2264591705.html

AZN -- cancer (olaparib), depression -- poor results
NVS -- Rasilez -- blood pressure - placebo better
ASY.PA -- oral multiple sclerosis (MS) drug Aubagio -- no better than Rebif
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up